Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects SHANGHAI, Feb. 7, 2025 /PRNewswire/ -- Today, Nuance Pharma ("Nuance") announced that the Pharmaceutical Administration Bureau Macau approved Ohtuvayre™ (ensifentrine) for the maintenance treatment...
XIAMEN, China, Feb. 6, 2025 /PRNewswire/ -- EPWK HOLDINGS LTD. (the "Company") (NasdaqGM: EPWK), a company that connects businesses with great talents through innovative...